Presentation TCT 2024 The Evolution of Transcatheter Mitral Valve Repair: Technical and Procedural Insights from an Early Human Feasibility Program (Case-Based) Presenter: Alexandre Abizaid October 29, 2024
Presentation TCT 2024 TCT 165: Comparison of Paravalvular Leak in SAPIEN 3 and EVOLUT PRO Valves in Transcatheter Aortic Valve Replacement: A Multicenter Registry Presenter: Anthony Matta October 28, 2024
Presentation NY Valves 2024 The EVOLUT Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities Presenter: John K. Forrest June 07, 2024
Presentation TCT 2023 Optimizing Outcomes With Self-Expanding Valves: The OPTIMIZE PRO Study and Evolut PRO Plus and FX Valves Presenter: Steven Yakubov October 25, 2023
Presentation TCT 2023 TCT 248: Assessment of Coronary Cannulation, Commissure and Coronary Alignment post TAVR with the New Supra-Annular, Self-Expanding Evolut FX System Presenter: Guilherme Attizzani October 25, 2023
Presentation TCT 2023 TCT 519: Coronary access and percutaneous coronary intervention feasibility after transcatheter aortic valve replacement in failed bioprosthetic valves with ACURATE neo2 versus Evolut PRO+ Presenter: Francesco Giannini October 25, 2023
Presentation TCT 2023 TCT 383: Feasibility of TAV-in-TAV in Evolut valves using in-vivo CT sizing and its impact on coronary obstruction and patient prosthesis mismatch Presenter: Atsushi Okada October 24, 2023
Presentation TCT 2022 Patient Selection for PFO Closure in 2022: An Evolutionary Process Presenter: Reda Ibrahim September 18, 2022
Presentation TVT 2022 Patient Selection for PFO Closure in 2022: An Evolutionary Process Presenter: Reda Ibrahim June 10, 2022
Presentation TVT 2022 Proven Safety through MitraClip G4 and Evolution of TEER Presenter: Rahul Sharma June 09, 2022
Presentation TVT 2022 Temporal Trends and Contemporary Outcomes After Transcatheter Aortic Valve Replacement With Latest-Generation Evolut PRO/PRO+: Insights From the NEOPRO and NEOPRO-2 Registries Presenter: Andrea Scotti June 09, 2022
Presentation TVT 2022 Progress in Self-Expanding TAVR: Evolut PRO Plus and Beyond Presenter: John K. Forrest June 08, 2022
Presentation TCT 2020 Grading FMR Severity: Evolution of the Concept and Evolving Data Presenter: Paul Grayburn October 14, 2020
Presentation TVT 2020 Transcatheter Aortic Valve Replacement using an Evolut PRO Bioprosthesis in Low Risk Patients with Aortic Stenosis Presenter: Bruce Rutkin June 20, 2020
Presentation TVT 2020 Transcatheter Aortic Valve Replacement with Self-Expandable Supra Annular Valves for Failed Surgical Bioprostheses: Insights From the TVT Registry Presenter: Guilherme F. Attizzani June 20, 2020
Presentation TCT 2019 WATCHMAN: Device Characteristics, Procedural Technique, Clinical Outcomes, Ongoing Studies, and Evolution to WATCHMAN FLX Presenter: Saibal Kar September 26, 2019
Presentation TCT 2019 COAPT, Partner 2, and Evolut Low-Risk Trial Synopsis and What They Mean Moving Forward Presenter: Elizabeth Perpetua September 25, 2019
Presentation TVT 2019 Hemodynamic Outcomes and Predictors of Prosthesis-Patient Mismatch After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients: Results from the Evolut Low-Risk Trial Presenter: Mubashir Mumtaz June 14, 2019
Presentation TVT 2019 3 Illustrative Cases (Optimal Valve Sizing, Reducing New Pacemakers, and Coronary Access Issues) – A Case-Based Discussion Presenter: Stanley Chetcuti June 13, 2019